Dara Wright
Insider
First SEC filing: Dec. 17, 2019 · Latest: Dec. 17, 2019
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 16, 2023 | BIO | M | 502 | · | · | 503 Direct | -49.95% | Disposed | (price as of 2026-10-02) |
| Dec. 16, 2023 | BIO | F | 174 | $306.12 | $53,265 | 1,827 Direct | -8.70% | Disposed | 20.6% (price as of 2026-10-02) |
| Dec. 16, 2023 | BIO | M | 502 | · | · | 2,001 Direct | +33.49% | Acquired | (price as of 2026-10-02) |
| Dec. 12, 2023 | BIO | S | 1,200 | $299.16 | $358,992 | 1,499 Direct | -44.46% | Disposed | 23.4% (price as of 2026-10-02) |
| Sept. 2, 2023 | BIO | M | 433 | · | · | 434 Direct | -49.94% | Disposed | (price as of 2026-10-02) |
| Sept. 2, 2023 | BIO | F | 150 | $394.60 | $59,190 | 2,682 Direct | -5.30% | Disposed | -6.5% (price as of 2026-10-02) |
| Sept. 2, 2023 | BIO | M | 433 | · | · | 2,832 Direct | +18.05% | Acquired | (price as of 2026-10-02) |
| Sept. 1, 2023 | BIO | M | 405 | · | · | 811 Direct | -33.31% | Disposed | (price as of 2026-10-02) |
| Sept. 1, 2023 | BIO | M | 520 | · | · | 1,562 Direct | -24.98% | Disposed | (price as of 2026-10-02) |
| Sept. 1, 2023 | BIO | A | 3,005 | · | · | 3,005 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 1, 2023 | BIO | F | 141 | $394.60 | $55,639 | 2,399 Direct | -5.55% | Disposed | -6.5% (price as of 2026-10-02) |
| Sept. 1, 2023 | BIO | M | 405 | · | · | 2,540 Direct | +18.97% | Acquired | (price as of 2026-10-02) |
| Sept. 1, 2023 | BIO | F | 180 | $394.60 | $71,028 | 2,135 Direct | -7.78% | Disposed | -6.5% (price as of 2026-10-02) |
| Sept. 1, 2023 | BIO | M | 520 | · | · | 2,315 Direct | +28.97% | Acquired | (price as of 2026-10-02) |
| Dec. 16, 2022 | BIO | M | 502 | · | · | 1,005 Direct | -33.31% | Disposed | (price as of 2026-10-02) |
| Dec. 16, 2022 | BIO | F | 226 | $407.98 | $92,203 | 1,762 Direct | -11.37% | Disposed | -9.5% (price as of 2026-10-02) |
| Dec. 16, 2022 | BIO | M | 502 | · | · | 1,988 Direct | +33.78% | Acquired | (price as of 2026-10-02) |
| Sept. 2, 2022 | BIO | M | 433 | · | · | 867 Direct | -33.31% | Disposed | (price as of 2026-10-02) |
| Sept. 2, 2022 | BIO | F | 150 | $478.32 | $71,748 | 1,460 Direct | -9.32% | Disposed | -22.8% (price as of 2026-10-02) |
| Sept. 2, 2022 | BIO | M | 433 | · | · | 1,610 Direct | +36.79% | Acquired | (price as of 2026-10-02) |
| Sept. 1, 2022 | BIO | M | 405 | · | · | 1,216 Direct | -24.98% | Disposed | (price as of 2026-10-02) |
| Sept. 1, 2022 | BIO | A | 2,082 | · | · | 2,082 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 1, 2022 | BIO | F | 141 | $486.25 | $68,561 | 1,177 Direct | -10.70% | Disposed | -24.1% (price as of 2026-10-02) |
| Sept. 1, 2022 | BIO | M | 405 | · | · | 1,318 Direct | +44.36% | Acquired | (price as of 2026-10-02) |
| Dec. 16, 2021 | BIO | M | 502 | · | · | 1,507 Direct | -24.99% | Disposed | (price as of 2026-10-02) |
| Dec. 16, 2021 | BIO | F | 221 | $734.34 | $162,289 | 892 Direct | -19.86% | Disposed | -49.7% (price as of 2026-10-02) |
| Dec. 16, 2021 | BIO | M | 502 | · | · | 1,113 Direct | +82.16% | Acquired | (price as of 2026-10-02) |
| Sept. 2, 2021 | BIO | M | 433 | · | · | 1,300 Direct | -24.99% | Disposed | (price as of 2026-10-02) |
| Sept. 2, 2021 | BIO | F | 150 | $825.77 | $123,866 | 611 Direct | -19.71% | Disposed | -55.3% (price as of 2026-10-02) |
| Sept. 2, 2021 | BIO | M | 433 | · | · | 761 Direct | +132.01% | Acquired | (price as of 2026-10-02) |
| Sept. 1, 2021 | BIO | A | 1,621 | · | · | 1,621 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 1, 2021 | BIO | A | 1,621 | · | · | 1,621 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 16, 2020 | BIO | M | 502 | · | · | 2,009 Direct | -19.99% | Disposed | (price as of 2026-10-02) |
| Dec. 16, 2020 | BIO | F | 174 | $576.72 | $100,349 | 328 Direct | -34.66% | Disposed | -36.0% (price as of 2026-10-02) |
| Dec. 16, 2020 | BIO | M | 502 | · | · | 502 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 2, 2020 | BIO | A | 1,733 | · | · | 1,733 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 2, 2020 | BIO | A | 1,733 | · | · | 1,733 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 16, 2019 | BIO | A | 2,511 | · | · | 2,511 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 16, 2019 | BIO | A | 2,511 | · | · | 2,511 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 16, 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 502 | Disposed |
| Sept. 2, 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 433 | Disposed |
| Sept. 1, 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 405 | Disposed |
| Sept. 1, 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 520 | Disposed |
| Sept. 1, 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 3,005 | Acquired |
| Dec. 16, 2022 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 502 | Disposed |
| Sept. 2, 2022 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 433 | Disposed |
| Sept. 1, 2022 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 405 | Disposed |
| Sept. 1, 2022 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 2,082 | Acquired |
| Dec. 16, 2021 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 502 | Disposed |
| Sept. 2, 2021 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 433 | Disposed |
| Sept. 1, 2021 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock | $814.95 | Sept. 1, 2031 | 1,621 | Acquired |
| Sept. 1, 2021 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 1,621 | Acquired |
| Dec. 16, 2020 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 502 | Disposed |
| Sept. 2, 2020 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 1,733 | Acquired |
| Sept. 2, 2020 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock | $524.30 | Sept. 2, 2030 | 1,733 | Acquired |
| Dec. 16, 2019 | BIO | Restricted Stock Units | Bio-Rad A Common Stock | · | · | 2,511 | Acquired |
| Dec. 16, 2019 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock | $366.89 | Dec. 16, 2029 | 2,511 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Dec. 17, 2019 | BIO | No securities beneficially owned | 0 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $562,390 | · | · | · | · | · | $17,760 | $2,133,126 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.